SQLab ๋Œ€์™ธ๊ณต๋ฌธ
2020. 01. 16

๊ณต๋ฌธ ์ œ20-01ํ˜ธ

์•ˆ๋…•ํ•˜์‹ญ๋‹ˆ๊นŒ?์ €ํฌ SQLab์„ ์ด์šฉํ•ด ์ฃผ์…”์„œ ๊ฐ์‚ฌํ•ฉ๋‹ˆ๋‹ค.๊ณต๋ฌธ ์ œ20-01ํ˜ธ ๋ฐœ์†ก ์•ˆ๋‚ด ์ž…๋‹ˆ๋‹ค.[๊ฒ€์‚ฌ์ •๋ณด ๋ณ€๊ฒฝ์•ˆ๋‚ด]: Anti platelet Ab, Platelet associatedAb IgG, T3 uptake, Anti-RNP...
2019. 12. 30

๊ณต๋ฌธ ์ œ19-45ํ˜ธ

์•ˆ๋…•ํ•˜์‹ญ๋‹ˆ๊นŒ?์ €ํฌ SQLab์„ ์ด์šฉํ•ด ์ฃผ์…”์„œ ๊ฐ์‚ฌํ•ฉ๋‹ˆ๋‹ค.๊ณต๋ฌธ ์ œ19-45ํ˜ธ ๋ฐœ์†ก์•ˆ๋‚ด ์ž…๋‹ˆ๋‹ค.-2020๋…„ ๊ฒ€์‚ฌ์ˆ˜๊ฐ€ ์•ˆ๋‚ด์ ์šฉ์ผ : 2020๋…„ 01์›” 01์ผ ์ ‘์ˆ˜๋ถ„ ๋ถ€ํ„ฐ๋ณ„์ฒจ1. ๋ณด๊ฑด๋ณต์ง€๋ถ€ ๊ณ ์‹œ ์ œ2019-214ํ˜ธ๋ณ„์ฒจ2. 2020๋…„ ๊ฒ€์‚ฌ์ˆ˜๊ฐ€...
2019. 12. 19

๊ณต๋ฌธ ์ œ19-44ํ˜ธ

์•ˆ๋…•ํ•˜์‹ญ๋‹ˆ๊นŒ?์ €ํฌ SQLab์„ ์ด์šฉํ•ด ์ฃผ์…”์„œ ๊ฐ์‚ฌํ•ฉ๋‹ˆ๋‹ค.๊ณต๋ฌธ ์ œ19-44ํ˜ธ ๋ฐœ์†ก์•ˆ๋‚ด ์ž…๋‹ˆ๋‹ค.-๊ฒ€์ฒด๊ฒ€์‚ฌ ์งˆ ๊ฐ€์‚ฐ ํ‰๊ฐ€ ๋“ฑ๊ธ‰ ์•ˆ๋‚ด(2020๋…„ 1๋ถ„๊ธฐ)๋ณด๋‹ค ์ž์„ธํ•œ ๋‚ด์šฉ์€ ์ฒจ๋ถ€ํŒŒ์ผ์„ ์ฐธ๊ณ ํ•˜์‹œ๊ธฐ ๋ฐ”๋ผ๋ฉฐ, ๋ฌธ์˜์‚ฌํ•ญ์ด ์žˆ์œผ์‹œ๋ฉด์•„๋ž˜์˜ ์—ฐ๋ฝ์ฒ˜๋กœ ์–ธ์ œ...
2019. 12. 14

๊ณต๋ฌธ ์ œ19-43ํ˜ธ

์•ˆ๋…•ํ•˜์‹ญ๋‹ˆ๊นŒ?์ €ํฌ SQLab์„ ์ด์šฉํ•ด ์ฃผ์…”์„œ ๊ฐ์‚ฌํ•ฉ๋‹ˆ๋‹ค.๊ณต๋ฌธ ์ œ19-43ํ˜ธ ๋ฐœ์†ก ์•ˆ๋‚ด ์ž…๋‹ˆ๋‹ค.[๊ฒ€์‚ฌ์ •๋ณด ๋ณ€๊ฒฝ์•ˆ๋‚ด]: CMV DNA ์ •์„ฑ, Avellino cornealdystrophymutation, HCV RNA ์ •๋Ÿ‰, Toxopl...
2019. 11. 22

๊ณต๋ฌธ ์ œ19-41ํ˜ธ

์•ˆ๋…•ํ•˜์‹ญ๋‹ˆ๊นŒ?์ €ํฌ SQLab์„ ์ด์šฉํ•ด ์ฃผ์…”์„œ ๊ฐ์‚ฌํ•ฉ๋‹ˆ๋‹ค.๊ณต๋ฌธ ์ œ19-41ํ˜ธ ๋ฐœ์†ก ์•ˆ๋‚ด ์ž…๋‹ˆ๋‹ค.[๊ฒ€์‚ฌ์ •๋ณด ๋ณ€๊ฒฝ์•ˆ๋‚ด]: DHEA-S, HSV type I/II IgG(S), MAST allergy, AMH, HIV RNA ์ •๋Ÿ‰, Solu...
2019. 10. 30

๊ณต๋ฌธ ์ œ19-39ํ˜ธ

์•ˆ๋…•ํ•˜์‹ญ๋‹ˆ๊นŒ?์ €ํฌ SQLab์„ ์ด์šฉํ•ด ์ฃผ์…”์„œ ๊ฐ์‚ฌํ•ฉ๋‹ˆ๋‹ค.๊ณต๋ฌธ ์ œ19-39ํ˜ธ ๋ฐœ์†ก ์•ˆ๋‚ด ์ž…๋‹ˆ๋‹ค.[๊ฒ€์‚ฌ์ •๋ณด ๋ณ€๊ฒฝ์•ˆ๋‚ด]: NTM sensitivity, AFB sensitivity, Rh Ab titer๋ณด๋‹ค ์ž์„ธํ•œ ๋‚ด์šฉ์€ ์ฒจ๋ถ€ํŒŒ์ผ์„ ์ฐธ๊ณ ํ•˜...